United Kingdom Archives

News and Trends 3 Nov 2016

Which Teams are taking home Lego Trophies from iGEM this year?

The iGEM 2016 results are in! The world’s largest synthetic biology competition took place in Boston from the 24th to the 31st of October, and European teams took home the grand prizes in two of the three tiers, Postgraduate, Undergraduate and High School. The winners and their projects are listed below. Originally launched by Massachusetts Institute of Technology, […]

November 3, 2016 - 4 minutesmins - By Evelyn Warner

News and Trends 2 Nov 2016

NHS adopts Next-Gen Sequencing to Test for Birth Defects

Despite a lawsuit from Illumina, Premaitha forged ahead with its NGS-based non-invasive prenatal test; the NHS just adopted it as a standard screen. With its seemingly infinite applications, next-generation sequencing (NGS) is a hot area, especially for diagnostics biotechs. A number have been founded in recent years to develop prenatal tests for birth defects, and […]

November 2, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 31 Oct 2016

Meet the Jellyfish Medtech seeking to disrupt the Collagen Market

Jellyfish are a source of collagen: this is the idea behind the winner of Boost Cymru, a competition of the Life Sciences Hub Wales. We had a chat with Andrew Mearns-Spragg, CEO of Jellagen, about this promising startup. The jellyfish already has a place in Biotech’s hall of fame as the source of the gene for […]

October 31, 2016 - 5 minutesmins - By Denise Neves Gameiro

News and Trends 28 Oct 2016

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some of the most promising technologies in immuno-oncology: TCR and checkpoint inhibitors. Adaptimmune is an immuno-oncology billion-euro Biotech from the British Golden Triangle. Despite some trouble with the FDA recently, the company continues to forge ahead with its promising TCR technology. Now, […]

October 28, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Oct 2016

UPDATE: Immuno-Oncology Combo works on Lung Cancer Regardless of PD-L1 Type

AstraZeneca’s MedImmune (UK) has published phase Ib study results in The Lancet Oncology. These showed anti-tumour activity of a combination of investigational antibodies in patients with lung cancer. The trial considered patients undergoing treatment with durvalumab and tremelimumab, to see whether the drug combo could act therapeuticaly against locally advanced or metastatic non-small cell lung cancer (NSCLC), irrespective of […]

October 28, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 27 Oct 2016

Oxitec scales up Mosquito production with a new Factory in Brazil

Since Brazil became the first country in the world to deploy GM mosquitos, Oxitec has opened a factory there to produce its Friendly Aedes aegypti. Oxitec has opened a large-scale mosquito factory in Piracicaba, Brazil, to scale up production of their Friendly Aedes aegypti mosquitos. These mosquitos are effectively sterilized so they don’t transmit infectious […]

October 27, 2016 - 2 minutesmins - By Evelyn Warner

guitar singing music song Rawpixel.com fi

News and Trends 26 Oct 2016

Proteins can now Sing about their Anomalies to help cure Diseases

Researchers are generating melodies from proteins’ structures. It could be used to understand protein folding and anomalies that contribute to disease. Protein folding is an infamously difficult phenomenon to understand and predict from sequence data. A collaboration between a resident composer at the University of Tempere in Finland and a scientist at the Francis Crick […]

October 26, 2016 - 3 minutesmins - By Evelyn Warner

Screenshot 2016 10 18 at 5.42.27 PM e1476805403921

News and Trends 18 Oct 2016

This New Biotech wants to Regrow Neurons to cure Parkinson’s

Mavalon Therapeutics will develop a drug candidate for Parkinson’s that can stop the disease progression by activating the growth of dying neurons. Mavalon Therapeutics, born today in the UK, will be entirely dedicated to the development of a drug candidate to stop the progression of Parkinson’s. Domain Therapeutics has created this new company with a €9M investment […]

October 18, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Oct 2016

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

Just after the Nobel Prize was awarded to the study of autophagy, PhoreMost announces a collaboration to target the process in neurodegenerative diseases. PhoreMost is a drug discovery company that focuses on finding ‘undruggable’ targets, such as the KRAS cancer gene. Now, the company has announced a collaboration with the University of Cambridge to start working […]

October 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Oct 2016

It’s not over yet for Opdivo; AbbVie takes a stand in Leukemia

The Committee on Medicinal Products for Human Use (CHMP) has handed down a pair of positive opinions of Opdivo and AbbVie’s leukemia therapy in their quests for EMA approval. Before the European Commission reviews an application for market authorization, it crosses the collective desk of the Committee on Medicinal Products for Human Use (CHMP). If […]

October 17, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 13 Oct 2016

This Start-up sells Cheap 3D-printed Microscopes for Bacterial testing

What if you could print your own microscope to save money? WaterScope has designed a 3D-printed microscope for rapid water testing in the field on a budget. WaterScope is a spin-out from the University of Cambridge that 3D prints microscopes and sells them to anyone that requires low-cost equipment for their project or start-up. The funds will […]

October 13, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Oct 2016

Adaptimmune Revises TCR Protocol following Phase I/IIa Failure

Shares of Adaptimmune slid 12% yesterday morning after the company updated its TCR therapy to include fludarabine, which was linked to deaths in Juno’s CAR-T trials. Despite optimism that T-cells are the key to cancer cures, the field has taken a number of hits this year. Most recently, the FDA put a partial hold on […]

October 13, 2016 - 2 minutesmins - By Evelyn Warner

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Which Teams are taking home Lego Trophies from iGEM this year?

NHS adopts Next-Gen Sequencing to Test for Birth Defects

Meet the Jellyfish Medtech seeking to disrupt the Collagen Market

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

UPDATE: Immuno-Oncology Combo works on Lung Cancer Regardless of PD-L1 Type

Oxitec scales up Mosquito production with a new Factory in Brazil

Proteins can now Sing about their Anomalies to help cure Diseases

This New Biotech wants to Regrow Neurons to cure Parkinson’s

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

It’s not over yet for Opdivo; AbbVie takes a stand in Leukemia

This Start-up sells Cheap 3D-printed Microscopes for Bacterial testing

Adaptimmune Revises TCR Protocol following Phase I/IIa Failure

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!